Campbell & CO Investment Adviser LLC Ionis Pharmaceuticals Inc Transaction History

Campbell & CO Investment Adviser LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$42.03 - $53.55 $3.98 Million - $5.08 Million	94,772 New	94,772 $4.11 Million
Q3 2023 Nov 08, 2023	BUY	$38.5 - $47.13 $637,059 - $779,860	16,547 New	16,547 $750,000
Q4 2022 Feb 14, 2023	BUY	$37.12 - $46.52 $557,468 - $698,637	15,018 New	15,018 $567,000
Q2 2022 Aug 09, 2022	BUY	$31.71 - $43.0 $358,291 - $485,857	11,299 New	11,299 $418,000
Q1 2022 May 09, 2022	SELL	$29.88 - $37.04 $518,298 - $642,495	-17,346 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$25.61 - $35.1 $65,305 - $89,505	-2,550 Reduced 12.82%	17,346 $528,000
Q3 2021 Nov 10, 2021	BUY	$33.54 - $40.55 $667,311 - $806,782	19,896 New	19,896 $667,000
Q1 2020 Apr 29, 2020	SELL	$41.6 - $63.4 $678,537 - $1.03 Million	-16,311 Closed	0 $0
Q4 2019 Jan 23, 2020	BUY	$53.85 - $65.27 $878,347 - $1.06 Million	16,311 New	16,311 $985,000
Q3 2019 Oct 16, 2019	SELL	$59.06 - $72.15 $335,519 - $409,884	-5,681 Closed	0 $0
Q2 2019 Jul 10, 2019	BUY	$62.09 - $86.14 $352,733 - $489,361	5,681 New	5,681 $365,000

394

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.8B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.